FRANKLIN LAKES, N.J.,
May 23, 2017 /PRNewswire/ -- The
Board of Directors of BD (Becton, Dickinson and Company) (NYSE:
BDX) has declared a quarterly dividend of 73
cents per common share, payable on June 30, 2017 to holders of record on
June 9, 2017. The indicated annual
dividend rate is $2.92 per share.
About BD
BD is a global medical technology company that is advancing the
world of health by improving medical discovery, diagnostics and the
delivery of care. BD leads in patient and health care worker safety
and the technologies that enable medical research and clinical
laboratories. The company provides innovative solutions that help
advance medical research and genomics, enhance the diagnosis of
infectious disease and cancer, improve medication management,
promote infection prevention, equip surgical and interventional
procedures, and support the management of diabetes. The company
partners with organizations around the world to address some of the
most challenging global health issues. BD has nearly 50,000
associates across 50 countries who work in close collaboration with
customers and partners to help enhance outcomes, lower health care
delivery costs, increase efficiencies, improve health care safety
and expand access to health. For more information on BD, please
visit bd.com.
Contact:
Kristen Cardillo, Corporate
Communications – 201-847-5657
Monique N. Dolecki, Investor
Relations – 201-847-5378
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/bd-board-declares-dividend-300462739.html
SOURCE BD (Becton, Dickinson and Company)